News for TG Therapeutics Stock (TGTX)

TGTX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 16, 2022 in the Class Action Filed on Behalf of TG Therapeutics, Inc. Shareholders

PRNewsWire • 09/13/22

TGTX FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

Newsfile Corp • 09/12/22

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 09/12/22

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind TG Therapeutics Investors of a Lead Plaintiff Deadline of September 16, 2022

PRNewsWire • 09/12/22

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TG Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - TGTX

Newsfile Corp • 09/10/22

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 09/09/22

TG Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

GlobeNewsWire • 09/09/22

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

PRNewsWire • 09/09/22

TG THERAPEUTICS, INC. (TGTX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against TG Therapeutics, Inc. (TGTX)

Newsfile Corp • 09/08/22

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 09/08/22

ROSEN, National Trial Lawyers, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

Newsfile Corp • 09/06/22

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 09/06/22

ROSEN, A TOP RANKED FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

Newsfile Corp • 09/04/22

ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

Newsfile Corp • 09/02/22

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 09/02/22

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

PRNewsWire • 09/01/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/30/22

Wall Street Analysts Predict a 225% Upside in TG Therapeutics (TGTX): Here's What You Should Know

Zacks Investment Research • 08/29/22

ROSEN, SKILLED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/28/22

ROSEN, LEADING INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

PRNewsWire • 08/26/22

TG Therapeutics Announces Results from the ULTIMATE I & II Phase 3 Trials of Investigational Ublituximab in RMS Published in The New England Journal of Medicine

GlobeNewsWire • 08/25/22

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Securities Class Action Filed

Newsfile Corp • 08/24/22

ROSEN, Top Ranked Investor Counsel, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/20/22

TGTX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys, Securities Fraud Lawsuit Pending

Newsfile Corp • 08/17/22

ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

Newsfile Corp • 08/16/22